All In MedTech

Device Trial Radar · NCT07098195

To Evaluate the Performance and Safety of RisoR Crest Everolimus Eluting Coronary Stent System

An OPen-label, Multicentre, Single Arm, Clinical InvestigatIon to Evaluate PerFormance and Safety of RIsoR Crest EveRolimus Eluting Coronary Stent System

Last checked: Nov 20, 2026Latest source record: Aug 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

2,000

Planned (sponsor's estimate)

Start

Aug 18, 2025

Primary completion

Aug 17, 2027

Study completion Jan 17, 2028

Sponsor

Lead sponsor
Poly Medicure LimitedNot on our public-company list
Sponsor type
Industry
First posted
Aug 1, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study will evaluate the performance and safety of RisoR Crest Everolimus Eluting Coronary Stent System. A total of 2000 participants will be included in the study from India and Italy.

Conditions

  • Coronary Artery Disease
  • Coronary Artery Stenosis
  • Percutaneous Coronary Intervention
  • de Novo Lesions in Native Coronary Arteries

Interventions

  • Coronary StentDevice

    RisoR Crest Everolimus Eluting Coronary Stent System

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Target Lesion Failure (TLF)Time frame: 360 Days

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.